| Stem cell integrins: implications for ex-vivo culture and cellular therapies ABJ Prowse, F Chong, PP Gray, TP Munro Stem cell research 6 (1), 1-12, 2011 | 200 | 2011 |
| Identification of potential pluripotency determinants for human embryonic stem cells following proteomic analysis of human and mouse fibroblast conditioned media ABJ Prowse, LR McQuade, KJ Bryant, H Marcal, PP Gray Journal of proteome research 6 (9), 3796-3807, 2007 | 121 | 2007 |
| A proteome analysis of conditioned media from human neonatal fibroblasts used in the maintenance of human embryonic stem cells ABJ Prowse, LR McQuade, KJ Bryant, DD Van Dyk, BE Tuch, PP Gray Proteomics 5 (4), 978-989, 2005 | 106 | 2005 |
| Long term culture of human embryonic stem cells on recombinant vitronectin in ascorbate free media ABJ Prowse, MR Doran, JJ Cooper-White, F Chong, TP Munro, ... Biomaterials 31 (32), 8281-8288, 2010 | 105 | 2010 |
| Analysis of mitochondrial function and localisation during human embryonic stem cell differentiation in vitro ABJ Prowse, F Chong, DA Elliott, AG Elefanty, EG Stanley, PP Gray, ... PloS one 7 (12), e52214, 2012 | 59 | 2012 |
| Functional arrays of human pluripotent stem cell-derived cardiac microtissues N Thavandiran, C Hale, P Blit, ML Sandberg, ME McElvain, M Gagliardi, ... Scientific reports 10 (1), 6919, 2020 | 45 | 2020 |
| Defined high protein content surfaces for stem cell culture MR Doran, JE Frith, ABJ Prowse, J Fitzpatrick, EJ Wolvetang, TP Munro, ... Biomaterials 31 (19), 5137-5142, 2010 | 45 | 2010 |
| Transforming the promise of pluripotent stem cell-derived cardiomyocytes to a therapy: challenges and solutions for clinical trials ABJ Prowse, NE Timmins, TM Yau, RK Li, RD Weisel, G Keller, ... Canadian Journal of Cardiology 30 (11), 1335-1349, 2014 | 44 | 2014 |
| Thermoresponsive worms for expansion and release of human embryonic stem cells X Chen, ABJ Prowse, Z Jia, H Tellier, TP Munro, PP Gray, MJ Monteiro Biomacromolecules 15 (3), 844-855, 2014 | 36 | 2014 |
| Multiplexed staining of live human embryonic stem cells for flow cytometric analysis of pluripotency markers ABJ Prowse, J Wilson, GW Osborne, PP Gray, EJ Wolvetang Stem Cells and Development 18 (8), 1135-1140, 2009 | 13 | 2009 |
| A rapid, cost-effective method for counting human embryonic stem cell numbers as clumps ABJ Prowse, EJ Wolvetang, PP Gray Biotechniques 47 (1), 599-606, 2009 | 10 | 2009 |
| Methods for expansion of three-dimensional cultures of human embryonic stem cells using a thermoresponsive polymer X Chen, L Harkness, Z Jia, A Prowse, MJ Monteiro, PP Gray Tissue Engineering Part C: Methods 24 (3), 146-157, 2018 | 5 | 2018 |
| Generation of fibroblast-derived induced pluripotent stem cell (iPSC) lines from two paediatric patients with phenylketonuria D Veleva, M Ay, DA Ovchinnikov, ABJ Prowse, MJ Menezes, M Nafisinia Stem Cell Research 77, 103405, 2024 | 2 | 2024 |
| Cellular heterogeneity of pluripotent stem cell-derived cardiomyocyte grafts is mechanistically linked to treatable arrhythmias D Selvakumar, ZE Clayton, A Prowse, S Dingwall, SK Kim, L Reyes, ... Nature Cardiovascular Research 3 (2), 145-165, 2024 | 2 | 2024 |
| Cellular Heterogeneity of Pluripotent Stem Cell Derived Cardiomyocyte Grafts is Mechanistically Linked to Treatable Arrhythmias D Selvakumar, Z Clayton, A Prowse, S Dingwall, J George, H Shah, ... Heart, Lung and Circulation 31, S37-S38, 2022 | 1 | 2022 |
| PRODUCTION OF INDUCED PLURIPOTENT STEM CELL DERIVED CARDIOMYOCYTES IN A SCALABLE VERTICAL WHEEL BIOREACTOR SYSTEM S Dingwall, C Ongtenco, J Sun, D Power, P Gray, A Prowse Cytotherapy 26 (6), S223-S224, 2024 | | 2024 |
| Generation of two lymphoblastoid-derived induced pluripotent stem cell (iPSC) lines from patients with phenylketonuria D Veleva, M Ay, DA Ovchinnikov, ABJ Prowse, MJ Menezes, M Nafisinia Stem Cell Research 77, 103407, 2024 | | 2024 |
| Analysis of three characterization assays reveals ddPCR of LIN28A as the most sensitive for the detection of residual pluripotent stem cells in cellular therapy products J Sun, C Yates, S Dingwall, C Ongtengco, D Power, P Gray, A Prowse Cytotherapy, 2024 | | 2024 |
| Method development for the production of clinically relevant doses of human pluripotent stem cell derived cardiomyocytes A Prowse, S Dingwall, Z Clayton, D Selvakumar, J Chong, P Gray | | 2024 |
| Functional arrays of human pluripotent stem cell-derived cardiac microtissues T Nimalan, C Hale, B Patrick, ML Sandberg, ME McElvain, M Gagliardi, ... Scientific Reports (Nature Publisher Group), 2020 | | 2020 |
